This activity includes a caregiver perspective video.
Program Description
Chronic graft-versus-host disease (GVHD) is a complication of allogeneic stem cell transplant for which patients require persistent immunosuppressive therapy. Though corticosteroids are the mainstay of treatment in chronic GVHD, a significant portion of patients become refractory within the first year with poor prognosis. Several nonsteroidal agents have received FDA approval in recent years for treatment of chronic GVHD to provide greater long-term immunosuppression, but these are associated with access and treatment-related barriers that contribute to medication nonadherence. In this multidisciplinary panel discussion, experts will examine opportunities for oncology pharmacists on the multidisciplinary care team to optimize treatment selection for the management of chronic GVHD. A caregiver of a patient with chronic GVHD will join the panelists to share perspectives on challenges surrounding treatment compliance and the role of the cancer care team in providing supportive care during disease management.
Target audience: Oncology pharmacists
Type of activity: Application
Release date: April 25, 2023
Expiration date: June 25, 2023
Time to complete activity: 1.5 hours
Learner level: Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Apply recent and emerging clinical evidence into the selection of graft-versus-host disease (GVHD) prophylactic regimens
- Explore strategies to optimize adherence to GVHD prophylaxis
- Investigate treatment sequencing strategies in steroid-refractory chronic GVHD
- Determine the role of oncology pharmacists within the multidisciplinary care team in addressing the supportive care needs of patients with chronic GVHD
Amber B. Clemmons, PharmD, BCOP, FHOPA
Clinical Professor
University of Georgia College of Pharmacy
Clinical Pharmacy Specialist - Hematology/BMT
Augusta University (AU) Medical Center
PGY2 Oncology Residency Director | UGA / AU Medical Center
Augusta, Georgia
Tracy T. Douglas, DNP, RN, BMT-CN, NEA-BC
Manager of Transplant Services
The University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland
Jean A. Yared, MD
Associate Professor, Department of Medicine
University of Maryland School of Medicine
Director, Allogeneic Transplant Clinic
University of Maryland Medical Center
Associate Director, Clinical Research, TCT Program
University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland
Medical Writer for Panel Discussion
Spencer K. Yingling, PharmD, BCOP
Oncology Pharmacy Specialist – BMT/Hematologic Malignancies and Cellular Therapies
WVU Medicine
Adjunct Professor – Oncology
WVU School of Pharmacy
Morgantown, West Virginia
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-23-126-L01-P. The activity is available for CE credit through June 25, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Jean A. Yared, MD, has the following relevant financial relationships with commercial interests to disclose:
Advisory boards: Incyte, Sanofi, Kadmon
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Amber B. Clemmons, PharmD, BCOP, FHOPA
Tracy T. Douglas, DNP, RN, BMT-CN, NEA-BC
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Amy H. Seung, PharmD, BCOP, FHOPA, CHCP; Amy L. Morris, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta.
Medical Writing and Editorial Support
Spencer K. Yingling, PharmD, BCOP
Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms